Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Cheifetz

Showing results (71-80 of 263) with videos related to

Pageof 27
Sort By:
Nature Clinical Practice. Gastroenterology & Hepatology|May 5, 2006
Combined oral and topical mesalazine treatment for extensive ulcerative colitisAlan C Moss, Adam S Cheifetz, Mark A Peppercorn
Alimentary Pharmacology & Therapeutics|March 22, 2022
Letter: is blindly stopping thiopurines without confirming adequate anti-TNF concentrations shortsighted?Natália Sousa Freitas Queiroz, Konstantinos Papamichael, Adam S Cheifetz
The American Journal of Gastroenterology|September 7, 2010
Capsule endoscopy in suspected Crohn's disease: "yield" does not equal "diagnosis"Glen A Doherty, Alan C Moss, Adam S Cheifetz
European Journal of Oral Sciences|April 16, 1998
Analysis of intracellular osteopontin as a marker of osteoblastic cell differentiation and mesenchymal cell migrationR Zohar, S Cheifetz, C A McCulloch, et al.
Journal of Crohn'S & Colitis|February 24, 2023
Going Beyond a Treat-To-Target to a Treat-To-Clear and a Treat-To-Trough Therapeutic Strategy in Patients with Inflammatory Bowel Disease?Natália Sousa Freitas Queiroz, Adam S Cheifetz, Konstantinos Papamichael
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1986
Type beta transforming growth factor is an inhibitor of myogenic differentiationJ Massagué, S Cheifetz, T Endo, et al.
Alimentary Pharmacology & Therapeutics|July 2, 2013
Letter: international IBD practice guidelines -- authors' replyJ D Feuerstein, D A Leffler, A S Cheifetz
PCR Methods and Applications|June 1, 1995
Development of competitive PCR and the QPCR system 5000 as a transcription-based screenE T Wilkinson, S Cheifetz, S A De Grandis
The Journal of Cell Biology|December 1, 1989
Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-betaJ L Andres, K Stanley, S Cheifetz, et al.
The Journal of Biological Chemistry|December 5, 1991
Purification of the transforming growth factor-beta (TGF-beta) binding proteoglycan betaglycanJ L Andres, L Rönnstrand, S Cheifetz, et al.
Pageof 27

Showing results (71-80 of 263) with videos related to

Sort By:
Pageof 27
Nature Clinical Practice. Gastroenterology & Hepatology|May 5, 2006
Combined oral and topical mesalazine treatment for extensive ulcerative colitisAlan C Moss, Adam S Cheifetz, Mark A Peppercorn
Alimentary Pharmacology & Therapeutics|March 22, 2022
Letter: is blindly stopping thiopurines without confirming adequate anti-TNF concentrations shortsighted?Natália Sousa Freitas Queiroz, Konstantinos Papamichael, Adam S Cheifetz
The American Journal of Gastroenterology|September 7, 2010
Capsule endoscopy in suspected Crohn's disease: "yield" does not equal "diagnosis"Glen A Doherty, Alan C Moss, Adam S Cheifetz
European Journal of Oral Sciences|April 16, 1998
Analysis of intracellular osteopontin as a marker of osteoblastic cell differentiation and mesenchymal cell migrationR Zohar, S Cheifetz, C A McCulloch, et al.
Journal of Crohn'S & Colitis|February 24, 2023
Going Beyond a Treat-To-Target to a Treat-To-Clear and a Treat-To-Trough Therapeutic Strategy in Patients with Inflammatory Bowel Disease?Natália Sousa Freitas Queiroz, Adam S Cheifetz, Konstantinos Papamichael
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1986
Type beta transforming growth factor is an inhibitor of myogenic differentiationJ Massagué, S Cheifetz, T Endo, et al.
Alimentary Pharmacology & Therapeutics|July 2, 2013
Letter: international IBD practice guidelines -- authors' replyJ D Feuerstein, D A Leffler, A S Cheifetz
PCR Methods and Applications|June 1, 1995
Development of competitive PCR and the QPCR system 5000 as a transcription-based screenE T Wilkinson, S Cheifetz, S A De Grandis
The Journal of Cell Biology|December 1, 1989
Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-betaJ L Andres, K Stanley, S Cheifetz, et al.
The Journal of Biological Chemistry|December 5, 1991
Purification of the transforming growth factor-beta (TGF-beta) binding proteoglycan betaglycanJ L Andres, L Rönnstrand, S Cheifetz, et al.
Pageof 27